Concurrently, hyperoside markedly upregulated the expression of osteogenesis-related markers, such as Osteopontin (OPN), RUNX2, and Osteocalcin, at both the mRNA and protein levels, indicating its efficacy in inducing osteogenic differentiation of osteosarcoma cells. The gene discussed is SPP1; the disease is osteosarcoma.